![CIRRUS 6000 CIRRUS 6000]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.100.56.file/ga_cropped_1.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.360.203.file/ga_cropped_1.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.768.432.file/ga_cropped_1.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1024.576.file/ga_cropped_1.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1280.720.file/ga_cropped_1.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1440.810.file/ga_cropped_1.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original./ga_cropped_1.jpg"})
CIRRUS OCT
Toolkit AMD et atrophie géographique
Donnez à vos patients toutes les chances d'accéder à une nouvelle ère de traitement et de prise en charge de la dégénérescence maculaire liée à l'âge grâce à l'Advanced RPE Analysis et ZEISS AngioPlex, au tookit AMD et GA (atrophie géographique) de ZEISS CIRRUS.
La dégénérescence maculaire liée à l'âge (AMD) est la principale cause de perte de vision grave et irréversible chez les personnes âgées de plus de 60 ans. Elle se développe à un rythme alarmant dans le monde entier. Vos patients en souffrent peut-être aussi. On estime que 196 millions de personnes étaient atteintes d'AMD en 2020 et que ce chiffre atteindra 288 millions en 2040. Pourtant, 25 % des cas ne sont pas diagnostiqués dans le cadre des soins oculaires primaires.1,2 Ce chiffre représente une augmentation de plus de 46 %, soit 92 millions de personnes supplémentaires qui, bien qu'elles n'en aient pas conscience, risquent de perdre la vue. Nous avons une solution. Apprenez à utiliser l'Advanced RPE Analysis et AngioPlex® en tant que toolkit AMD et GA pour le diagnostic et la prise en charge de vos patients atteints de dégénérescence maculaire liée à l'âge.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.100.100.80,0,560,480.file/196-million.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.360.360.80,0,560,480.file/196-million.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png"})
On estime que 196 millions de personnes dans le monde étaient atteintes d'AMD en 2020.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.100.100.23,0,428,405.file/affect-central-vision_lrg.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.360.360.23,0,428,405.file/affect-central-vision_lrg.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg"})
Cette maladie affecte la vision centrale et 92 millions de personnes supplémentaires risquent de perdre la vue.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.100.100.80,0,560,480.file/60-plus.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.360.360.80,0,560,480.file/60-plus.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png"})
Les adultes de plus de 60 ans présentent un risque plus élevé de la développer.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.100.100.23,0,428,405.file/risk-factors_lrg.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.360.360.23,0,428,405.file/risk-factors_lrg.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg"})
Le tabagisme, les antécédents familiaux, une mauvaise alimentation, la sédentarité et l'exposition au soleil sont quelques-uns des facteurs de risque de l'AMD.
Une nouvelle ère de l'atrophie géographique
Le rôle de l'OCT swept source
![Advanced RPE Analysis Advanced RPE Analysis]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg"})
Advanced RPE Analysis
Mesure quantitative et comparaison des données historiques
L'Advanced RPE Analysis, disponible sur ZEISS CIRRUS OCT, a été spécifiquement créée pour aider les praticiens à gérer la dégénérescence maculaire liée à l'âge non néovasculaire sous toutes ses formes.
![AngioPlex AngioPlex]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.100.56.0,130,1341,886.file/article_2_figure_2-octa_report.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.360.203.0,130,1341,886.file/article_2_figure_2-octa_report.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.768.432.0,130,1341,886.file/article_2_figure_2-octa_report.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1024.576.0,130,1341,886.file/article_2_figure_2-octa_report.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1280.720.0,130,1341,886.file/article_2_figure_2-octa_report.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1341.754.0,130,1341,886.file/article_2_figure_2-octa_report.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1341.754.0,130,1341,886.file/article_2_figure_2-octa_report.png"})
AngioPlex
L'importance de la détection précoce de la progression
Les systèmes d'OCT-angiographie (OCTA), tels que ZEISS CIRRUS AngioPlex®, continuent de repousser les limites de l'imagerie oculaire afin que les cliniciens puissent mieux prendre en charge leurs patients.
![Un modèle de soins collaboratifs Un modèle de soins collaboratifs]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.100.56.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.360.203.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.768.432.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1024.576.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1280.720.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1440.810.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1920.1080.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png"})
Un modèle de soins collaboratifs
Optimiser le processus pour les nouveaux patients
ZEISS CIRRUS OCT, avec Advanced RPE Analysis et AngioPlex®, peut constituer la base sur laquelle les optométristes et les ophtalmologistes peuvent détecter et surveiller toutes les formes d'AMD.
Téléchargements
Contactez-nous !
Services disponibles
-
1
Wong, Wan Ling, et al. « Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. » The Lancet Global Health 2.2 (2014): e106-e116
-
2
Neely DC, Bray KJ, Huisingh CE, et al. Prevalence of undiagnosed age-related macular degeneration in primary eye care. BMC Ophthalmol. 2017;135(6):570-5